Catalyzing dopamine by the enzyme monoamine oxidase-B (MAO-B), which is increased in the brain, is the cause of decreased dopamine levels, hence indicating MAO-B is a good target to maintain dopamine levels in Parkinson's diseases [46]. The gene discussed is MAOB; the disease is Parkinson disease.